top of page
MEMBERS
Ji Hyun Go, M.S.
INTERNSHIP
AFFILIATION
Onconic Therapeutics Inc., Republic of Korea
DEPARTMENT
Pharmacology Team
EDUCATION
• 2016 – 2017 M.S., Biotechnology, Korea University, Seoul, Republic of Korea
• 2010 – 2013 B.S., Life Science, Sangmyung University, Seoul, Republic of Korea
CONTACT
PUBLICATIONS
• 2024 Novel pyrrolopyridine derivatives or salts thereof and pharmaceutical compositions comprising the same. Korean Patent Application No. 10-2024-0091301.
• 2023 Pharmaceutical composition for prevention or treatment of RON mutation-associated head and neck cancer. Korean Patent Application No. 10-2023-0045431.
• 2022 Pharmaceutical composition for prevention or treatment of RON mutation-associated cholangiocarcinoma. Korean Patent Application No. 10-2022-0055063.
• 2021 Pharmaceutical composition and method for prevention or treatment of RON mutation-associated non-small cell lung cancer. Korean Patent Application No. 10-2021-0063823.
• 2021 Pharmaceutical composition for prevention or treatment of KRAS mutation-associated cancer. Korean Patent Application No. 10-2021-0017066.
• 2018 Go JH, et al. Wogonin suppresses the LPS-enhanced invasiveness of MDA-MB-231 breast cancer cells by inhibiting the 5-LO/BLT2 cascade. International Journal of Molecular Medicine.
AWARDS
-
PRESENTATIONS
-
bottom of page